Author/Authors :
Gholami, Farhad Department of Internal Medicine - Faculty of Medicine - Mazandaran University of Medical Sciences, Mazandaran, Iran , Ghasemi, Ali Department of Hematology and Pediatrics - Mashhad University of Medical Sciences, Mashhad, Iran , Bahrami, Ahmad Reza Department of Biology - Faculty of Sciences - Ferdowsi University Of Mashhad, Mashhad, Iran , Bidkhouri, Hamid Reza Department of Biology - Faculty of Sciences - Ferdowsi University Of Mashhad, Mashhad, Iran , Naderi Mishkin, Hojat Academic Center for Education - Culture and Research (ACECR) - Stem Cell and Regenerative Medicine - Mashhad University of Medical Sciences, Mashhad, Iran , Pezeshki Rad, Masoud Associate Professor of Radiology - Mashhad University of Medical Sciences, Mashhad, Iran , Sharifipour, Farzaneh Division of Nephrology and Hypertension - Department of Internal Medicine - Mashhad University of Medical Sciences, Mashhad, Iran
Abstract :
Progenitor cells or mesenchymal stem cells are new cells, with renovation and regeneration ability and tissues repair. In recent years, administration of stem cells has been introduced to treat a variety of diseases including chronic allograft injury (CAI). It seems that stem cells can create a turning point in regenerative medicine through repair, replacement with damaged tissues or with their paracrine effects.
